TWiV 704: COVID-19 clinical update #44 with Dr. Daniel Griffin

January 9, 2021

In this COVID-19 clinical update, Daniel Griffin summarizes current status of vaccination in the US, discusses a study on convalescent sera from Argentina, use of remdesivir in patients with kidney disease, and provides further considerations on the use of Ct values in patient management.

Hosts: Daniel Griffin and Vincent Racaniello

Click arrow to play
Download TWiV 704 (19 MB .mp3, 32 min)
Subscribe (free): iTunesGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

2 comments on “TWiV 704: COVID-19 clinical update #44 with Dr. Daniel Griffin

  1. Brian Jan 9, 2021

    Do you have a reference for the 8 month immunity stated in the podcast?

  2. Dr. Kathleen Hofmans Jan 20, 2021

    Dr. Griffin, I’m and avid listener from Windsor Ontario Canada. I have a good friend who is in hospital with COVID 19. He was intubated a few days ago after a week of ICU treatment including high flow O2 most of that time. Also has pneumonia. His hospital physicians indicate that his situation is getting worse and there is no additional treatment they can recommend for him other than wait. Are you open to being contacted for a client consultation by his physicians? Your expertise would be greatly valued at this highly critical time.